Spyre Therapeutics (SYRE) EBT Margin (2015 - 2023)

Spyre Therapeutics posted quarterly EBT Margin of 31551.45% for Q2 2023, down 2798121.0% year-on-year from N/an in Q2 2022, and down 238.45% on a QoQ basis from 9322.22% in Q1 2023.

Spyre Therapeutics (SYRE) has 7 years of EBT Margin data on file, last reported at 31551.45% in Q2 2023.

  • For the quarter ending Q2 2023, EBT Margin fell 2798121.0% year-over-year to 31551.45%; the trailing twelve-month figure through Mar 2024 stood at 52933.58% (down 4623838.0% YoY), and the FY2023 full-year result was 38241.08%, down 3463649.0% from the prior year.
  • EBT Margin for Q2 2023 stood at 31551.45%, down from 9322.22% in the prior quarter.
  • Across five years, EBT Margin topped out at 56.15% in Q2 2021 and bottomed at 31551.45% in Q2 2023.
  • The 3-year median for EBT Margin is 3570.24% (2022), against an average of 7644.89%.
  • The widest annual swing landed in 2022, when EBT Margin tumbled 351409 bps; it then sank 2798121 bps in 2023.
  • A 3-year view of EBT Margin shows it stood at 560.46% in 2021, then plunged by 1895 bps to 11180.95% in 2022, then sank by 182 bps to 31551.45% in 2023.
  • The last three EBT Margin figures came in at 31551.45% (Q2 2023), 9322.22% (Q1 2023), and 11180.95% (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -6.40%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 41.95%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 23.05%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 18.99%
10 Spyre Therapeutics 5.55 Bn 5.55 Bn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2023 -31,551.45%
Mar 31, 2023 -9,322.22%
Dec 31, 2022 -11,180.95%
Sep 30, 2022 -10,599.43%
Jun 30, 2022 -3,570.24%
Mar 31, 2022 -1,794.13%
Dec 31, 2021 -560.46%
Sep 30, 2021 -169.01%
Jun 30, 2021 -56.15%
Jun 30, 2018 -395.58%
Mar 31, 2018 -536.56%
Dec 31, 2017 -436.75%
Sep 30, 2017 -623.47%
Jun 30, 2017 -447.60%
Mar 31, 2017 -635.03%
Dec 31, 2016 -438.73%
Sep 30, 2016 -542.12%
Jun 30, 2016 -394.83%
Mar 31, 2016 -528.64%
Dec 31, 2015 -251.48%
Sep 30, 2015 -317.99%
Jun 30, 2015 -41.64%